Drug combinations can induce potent synthetic lethalities by targeting multiple biological pathways at the same time. In these instances, multiple cellular vulnerabilities are exploited to induce effective cell death. Such combination therapies have the potential to bypass drug resistance mechanisms, limit adverse side effects via reduced dosing of individual agents, promote durable responses, and expand treatment options for patients.